RTC13

Names

[ Name ]:
RTC13

[Synonym ]:
(5Z)-2-Amino-5-[[5-(2-nitrophenyl)-2-furanyl]methylene]-4(5H)-thiazolone
(Z)-2-amino-5-((5-(2-nitrophenyl)furan-2-yl)methylene)thiazol-4(5H)-one
4(5H)-Thiazolone, 2-amino-5-[[5-(2-nitrophenyl)-2-furanyl]methylene]-, (5Z)-

Biological Activity

[Description]:

RTC13 restores dystrophin expression and improves muscle function in the mdx mouse model for Duchenne muscular dystrophy (DMD)[1].

[Related Catalog]:

Signaling Pathways >> Others >> Others

Research Areas >> Metabolic Disease

[In Vivo]

Animal Model: Wild-type (C57BL/10) mice at 10 to 12 weeks of age[1]. Dosage: 10 (n = 5), 30 (n = 5), 60 (n = 5) or 300 mg/kg (n = 5). Administration: Intraperitoneal Administration. Result: No changes were observed in liver and kidney weights at the time of necropsies, and Hematoxylin and Eosin (H&E) staining revealed the absence of histopathological changes.

[References]

[1]. Refik Kayali, et al. Read-through compound 13 restores dystrophin expression and improves muscle function in the mdx mouse model for Duchenne muscular dystrophy. Hum Mol Genet. 2012 Sep 15;21(18):4007-20.

Chemical & Physical Properties

[ Molecular Formula ]:
C₁₄H₉N₃O₄S

[ Molecular Weight ]:
315.30

[ Exact Mass ]:
315.03100

[ PSA ]:
139.71000

[ LogP ]:
3.44290